Influence of Menstrual Cycle Phase on Adaptations to Sprint Interval Training
1 other identifier
interventional
24
1 country
1
Brief Summary
Sprint interval training improves endurance performance and induces metabolic adaptations in muscle. Most research demonstrating these responses has been conducted in males, with limited studies evaluating changes to endurance performance and skeletal muscle oxidative capacity in females. Moreover, it is currently unknown if training in specific phases of the menstrual cycle influences adaptations to training. Thus, the purpose of the present study is to compare adaptations to 2 weeks of sprint interval training performed in the follicular vs. luteal phase of the menstrual cycle in healthy, eumenorrheic women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jan 2025
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2024
CompletedFirst Posted
Study publicly available on registry
December 20, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
April 29, 2026
April 1, 2026
1.5 years
December 16, 2024
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endurance performance
Time to completion and average power output during a 250kJ time trial
Before and after 2 weeks of exercise training
Secondary Outcomes (7)
Skeletal muscle mitochondrial content
Before and after 2 weeks of exercise training
Skeletal muscle mitochondrial enzyme activity
Before and after 2 weeks of exercise training
Skeletal muscle capillarization
Before and after 2 weeks of exercise training
Skeletal muscle lipid content
Before and after 2 weeks of exercise training
Skeletal muscle protein synthesis
Before and after 2 weeks of exercise training
- +2 more secondary outcomes
Study Arms (2)
Follicular Phase Training
ACTIVE COMPARATORExercise training in the follicular phase (\~days 1-14) of the participant's menstrual cycle
Luteal Phase Training
EXPERIMENTALExercise training in the luteal phase (\~days 15-28) of the participant's menstrual cycle
Interventions
6 sessions of sprint interval training over 2 weeks. Each session involves 4-6 x 30 second Wingate sprints with 4 minutes of recovery in between on a stationary bike
Eligibility Criteria
You may qualify if:
- Participating in 150 min of moderate-vigorous physical activity/week
- VO2peak of 'good' or above based on American College of Sport Medicine (ACSM) normative values(greater than 35.0ml/kg/min)
- Body mass index (BMI) between 18-27 kg/m2
- Performing 2-4 structured exercise sessions/week.
- Weight stable (within ± 2kg for at least 6 months)
- Non-smoker
- Menstrual cycle length of 27-35 days
- Minimal menstrual cycle length variability (less than 3 days)
- Ovulating monthly evidenced by a positive urinary luteinizing hormone surge
- Blood progesterone concentration greater than 16 nmol/L.
You may not qualify if:
- Hormonal contraceptive use within the last 3 months
- Polycystic ovarian syndrome (PCOS) or endometriosis
- Failure to meet MC verification criteria.
- Diagnosed with cardiovascular or metabolic disease, hyper- or hypogonadism, and/or PCOS
- The use of medication for managing blood glucose or lipid metabolism
- Current use of oral contraceptives or use within the last 3 months
- Irregular menstrual cycles (\<27 days or \>35 days)
- Pregnant or post-partum in the last 12 months, lactating or breast feeding within 3 months of the start of study, or menopausal
- Recreational smoking tobacco
- Inability to perform the study exercise protocols or follow the pre-trial dietary or physical activity controls
- Taking medications affecting substrate metabolism (corticosteroids or nSAIDs)
- Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Goldring Centre for High Performance Sport
Toronto, Ontario, M5S 2C9, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 16, 2024
First Posted
December 20, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share